CN104544049A - Vitamin C sodium lozenge and preparation process thereof - Google Patents
Vitamin C sodium lozenge and preparation process thereof Download PDFInfo
- Publication number
- CN104544049A CN104544049A CN201410764369.XA CN201410764369A CN104544049A CN 104544049 A CN104544049 A CN 104544049A CN 201410764369 A CN201410764369 A CN 201410764369A CN 104544049 A CN104544049 A CN 104544049A
- Authority
- CN
- China
- Prior art keywords
- sodium
- vitamine
- grape
- parts
- lozenge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007937 lozenge Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 26
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 title abstract 4
- 241000219095 Vitis Species 0.000 claims abstract description 45
- 235000009754 Vitis X bourquina Nutrition 0.000 claims abstract description 44
- 235000012333 Vitis X labruscana Nutrition 0.000 claims abstract description 44
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 44
- 235000012907 honey Nutrition 0.000 claims abstract description 31
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 26
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 239000011782 vitamin Substances 0.000 claims description 61
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 57
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 claims description 56
- 239000011734 sodium Substances 0.000 claims description 55
- 229910052708 sodium Inorganic materials 0.000 claims description 55
- 239000000843 powder Substances 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 26
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 24
- 240000000560 Citrus x paradisi Species 0.000 claims description 21
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 20
- 235000019674 grape juice Nutrition 0.000 claims description 17
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 11
- 238000001291 vacuum drying Methods 0.000 claims description 11
- 239000011122 softwood Substances 0.000 claims description 9
- 239000003826 tablet Substances 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 7
- 235000015203 fruit juice Nutrition 0.000 claims description 7
- 235000020985 whole grains Nutrition 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000000047 product Substances 0.000 abstract description 30
- 239000000796 flavoring agent Substances 0.000 abstract description 9
- 235000019634 flavors Nutrition 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 235000019195 vitamin supplement Nutrition 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 36
- 230000000694 effects Effects 0.000 description 17
- 235000019154 vitamin C Nutrition 0.000 description 16
- 239000011718 vitamin C Substances 0.000 description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 14
- 229930003268 Vitamin C Natural products 0.000 description 14
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000002932 luster Substances 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 238000000227 grinding Methods 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000007873 sieving Methods 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- -1 carrotene Natural products 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
- 235000001535 Ribes X utile Nutrition 0.000 description 1
- 235000016919 Ribes petraeum Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- NITJMAGUTXQPTR-UHFFFAOYSA-N [Cu].[Ca].[Fe] Chemical compound [Cu].[Ca].[Fe] NITJMAGUTXQPTR-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 235000019631 acid taste sensations Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000036649 mental concentration Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001379 nervous effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a vitamin C sodium lozenge and a preparation method thereof. The lozenge comprises the following raw materials in parts by weight: 500-1500 parts of fresh grape, 100-300 parts of vitamin C sodium, 150-350 parts of isomaltulose, 100-250 parts of Arabic gum, 40-150 parts of honey, and 0.5-2 parts of magnesium stearate. The original taste and flavor of the grape are preserved, the vitamin C sodium function is enhanced, and the lozenge is a good vitamin supplement and healthcare product; the lozenge is unique in production process, good in product forming, simple in process, easy to operate, and suitable for industrial production.
Description
Technical field
The invention belongs to field of health care food, relate to a kind of vitamine C sodium lozenge and preparation technology thereof.
Background technology
Vitamin C is also known as ascorbic acid, it is a kind of water soluble vitamin, there is the function of ascorbic acid disease, maintain the indispensable material of human normal physiological metabolism, there is important physiological function, amino acid and neurotransmission is participated in human body, the synthesis of collagen, it participates in hydroxylation reaction in body, for forming bone, tooth, between connective tissue and non-Epithelial cell, sticky thing institute is required, tooth can be maintained, bone, the normal function of blood vessel, increase the resistivity to disease, it also has the permeability reducing capillary, the function stimulating blood coagulation and the resistant function etc. increased infecting.In all kinds of crowd, have shortage in various degree according to interrelated data report vitamin C, when some indispositions appear in health, just should supplement appropriate vitamin in time and mineral matter improves deficiency disease, especially person in middle and old age should comparatively pay attention to.Vitamin C has prevention effect to numerous disease, the people that in body, vitamin C is high, absorbs the harmful elements such as lead, cadmium, chromium more hardly the people of contaminated environment work; More the people smoked eats and helps containing ascorbic food the resistance improving cell, keeps the elasticity of blood vessel, eliminates the nicotine in body; Be engaged in the people of strenuous exercise and highly intensive labour, these people, because of too much meeting large losses vitamin C of sweating, should be supplemented in time; Vitamin C Wheat Protein, replenishing vitamins C can suppress the generation of pigmented spots, promotes that it disappears; Aspirin, hypnotic, anticancer change medicine, tetracycline, calcium product, contraceptive, depressor etc., all can make body vitamin C reduce, and can cause other bad reaction, should replenishing vitamins C in time.
Vitamin C is clinical basic common drug, be widely used on various diseases prevention and therapy, because vitamin C aqueous ph value is close to about 2, therefore, acidity is comparatively large, orally uses oral cavity, throat esophagus and gastric stimulation comparatively large, unsuitable long-term taking, also be not suitable for taking with acidic drug simultaneously, use is subject to a definite limitation.And vitamine C sodium is ascorbic sodium salt, aqueous ph value is close to neutral, and its effect is identical with ascorbic acid, but owing to being sodium salt, so performance is more stable, no longer include ascorbic highly acid simultaneously, can for a long time and multi-medicament take simultaneously, be more better than vitamin C.Vitamine C sodium belongs to domestic and international widely used vitamin C intensified dose, progressively substitutes vitamin C and uses.
Grape is the fruit of Vitaceae Vitis.Main containing glucose in grape; up to 10%-30%; based on glucose; also containing fructose, protein, carrotene, vitamin, lecithin, tartaric acid, malic acid, calcium, phosphorus, iron etc.; to the successful improving appetite, protect liver, alleviate ascites and edema of lower extremity; can also plasma albumin be improved, reduce transaminase.TCM investigation show grape have fill blood, born fluid, spleen benefiting and stimulating the appetite, strong muscles and bones, relax the muscles and stimulate the blood circulation, the effect such as benefiting qi for tranquillization.Modern scientific research finds that again grape can reduce blood vessel embolism, reduces cholesterol and prevent the formation of tumour.
Honey, main component is fructose (molecular formula is C6H12O6), water, and also having trace element and the inorganic salts such as a small amount of copper iron calcium, is the highly finished product of the glucide that honeybee is led in honeycomb, and nature and flavor are sweet, flat, enter lung, spleen, large intestine channel.Have hypotensive, protect the effect such as liver, alleviating pain honey and be not only delicious nutriment, and be treatment various diseases, strong health and the medicine of promoting longevity.Honey is useful especially with the children being easy to the food digested for somagenic need high heat, and it can promote appetite, improves metabolism, people's spirit is good for refreshing and full of physical strength, improves body to the resistance of disease.
Isomaltoketose, because the secretion of insulin can not be caused after its digested absorption, also the activation of LPL activity would not be caused, so the existence of isomaltoketose makes grease be not easy to be absorbed in adipose tissue, isomaltoketose can also improve mental concentration and to releive nervous effect, it can not be caused the microorganism of decayed tooth to utilize by oral cavity, certainly also insoluble polydextrose would not be produced, isomaltoketose not only itself can not cause decayed tooth, more has the decayed tooth effect suppressing to be caused by sucrose.
At present, domestic and international market also has sodium vitamin C formulation to go on the market, mainly the formulation such as capsule, masticatory, lozenge, of less types, and be substantially all add the additive such as essence, pigment, be not suitable for long-term taking, and its composition is more single, and health care is poor.Now be badly in need of a kind of instant of exploitation, be of high nutritive value, easily store and take, and can long-term taking product.Finding by retrieving domestic and international prior art, also not preparing the report of vitamine C sodium lozenge with fresh grape and vitamine C sodium, honey, isomaltoketose for major ingredient at present.Based on above theoretical and Shortcomings, this patent develops vitamine C sodium lozenge on the basis solving many technical problems, is of high nutritive value, pure in mouth feel, safe without toxic side effect, and processing technology is relatively simple, produces than being easier to realize industrialization.
Summary of the invention
Content of the present invention is to provide a kind of vitamine C sodium lozenge of effective, taking convenience, pure taste, and prepares the preparation method of this lozenge.This product have ascorbic acid disease, anti-oxidant, antitumor, reduce lipid peroxidation, improve the effects such as immunity of organisms, cough-relieving wet one's whistle, can be used for prevention and supplemental treatment scurvy and various acute and chronic communicate illness or other diseases to strengthen Abwehrkraft des Koepers, after being ill convalescence During Wound Healing and the health therapy of anaphylactia.
Vitamine C sodium lozenge of the present invention adopts grape fresh goods to squeeze Normal juice, and pomace pulverizes achievement powder after adding isomaltoketose vacuum drying, and it retains the distinctive color of grape and smell, without the need to adding pigment and essence again.Uva powder adopts grape juice repeatedly to granulate after adding honey, Arabic gum, and particle adds vitamine C sodium compressing tablet, makes vitamine C sodium lozenge, and the present invention improves product original flavor, mouthfeel and health care, and it can make lozenge forming, and outward appearance is beautiful, and mouthfeel is good.
The present invention overcomes correlation technique difficult point by screening science prescription composition and unique preparation technology, by product prepared by this method, both the active ingredient of former grape, local flavor and color and luster had been kept, and improve product medicine and health care value, and vitamine C sodium pH value is close to neutral, it can alleviate acid stimulation, is easy to product and sucks.In prescription of the present invention, primary raw material vitamine C sodium has stronger clinical function, it can be used for a variety of causes and causes vitamin C deficiency to prevent, and also can be used for the treatment of hypovitaminosis C clinical disease, simultaneously because its PH is close to neutral, select it to make lozenge mouthfeel better, excitant is less.Granulate owing to directly adopting fresh grape Normal juice, it increases the active principle content such as vitamin C, and containing grape primary colors and peculiar fragrance, therefore, without the need to adding pigment and essence in prescription, retain color and luster and the local flavor of former grape greatly, embody the original taste of grape and the smell of product, strengthen Product Safety.Preparation technology of the present invention is easy simultaneously, be applicable to suitability for industrialized production, and product taking convenience safety, effect is good again, genuine, is applicable to all kinds of crowd's long-term taking.
Technical solution of the present invention is:
A kind of vitamine C sodium lozenge, raw material is made up of the component of following weight portion: fresh grape 500-1200 part, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
The above vitamine C sodium lozenge, raw material is preferably made up of the component of following weight portion: fresh grape 800-1000 part, vitamine C sodium 150-250 part, isomaltoketose 200-300 part, Arabic gum 150-200 part, honey 70-120 part, dolomol 1-1.5 part.
The above vitamine C sodium lozenge, raw material the best is preferably made up of the component of following weight portion: fresh grape 900 parts, vitamine C sodium 200 parts, isomaltoketose 150 parts, Arabic gum 175 parts, honey 95 parts, dolomol 1.0 parts.
The preparation method of the above vitamine C sodium lozenge, comprises the following steps:
1. take raw material by following weight portion: fresh grape 500-1200 part, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
2. get fresh grape, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice centrifuge or 200-300 mesh filter screen divide gets normal juice, for subsequent use;
3. get above-mentioned grape fruit residue, add isomaltoketose, mix, be dried to moisture content 3-10%, be ground into compound pomace fine powder, cross 200-300 mesh sieve, obtain compound grape fruit powder;
4. get above-mentioned compound grape fruit powder, add Arabic gum, mix, then add the original grape juice liquid that honey and step 2 obtain, softwood processed, granulates, and dry, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
The preparation method of the above vitamine C sodium lozenge, the granulation step in described step 4 preferably adopts multi granulating method: pulverize after making particle drying for the first time, then adopts original grape juice liquid multi granulating; And particle drying adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
The preparation method of the above vitamine C sodium lozenge, the original grape juice liquid obtained in step 2 first can be condensed into appropriate concentrate by the granulation step in described step 4, for granulating.
The preparation method of the above vitamine C sodium lozenge, described step 3 drying steps preferably adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
Also the nutritional labeling needed containing abundant human body in Grape Skin and grape pip and functional component, but add in lozenge and taste can be made to become puckery, affect mouthfeel, therefore go seed machine to remove with grape skinning machine, grape in producing, for the extraction of active ingredient after collection, as Zante currant does not then need seed.
In technique of the present invention, fresh grape to be squeezed the juice technology, it can retain the distinctive active ingredient of grape, fragrance and color and luster, and pomace add isomaltoketose drying after adopt micronizer to pulverize, and add honey softwood, the products taste of preparation is fine and smooth, fresh and sweet, more embodies the genuineness of product.Production technology of the present invention is unique, and formed product is good, and technique is simple, easy to operate, can be applicable to suitability for industrialized production.
According to the scientific and reasonable screening auxiliary material of the characteristic of vitamine C sodium and proportioning in the present invention's formula, in order to solve the difficult problem such as preparations shaping and products taste, in preparations shaping, select Arabic gum and honey as combination adhesive, they not only have stronger adhesion strength and soft elasticity, make product color good, outward appearance is beautiful, also has and strengthens product trophic function.Arabic gum is a kind of natural plants hydrosol, and it does not produce heat substantially, is good water-soluble dietary fiber, and medically Arabic gum also has the function reducing Blood Cholesterol; And in order to the mouthfeel of improving product and outward appearance, keep product lubricity and grape fragrance, adopt the honey with good performance of keeping humidity, the moisture that it can make product keep certain, prevent drying, and due to it be nonvolatile polyalcohol, keep the special aromatic function of product so also have, strengthen mouthfeel and the aroma effect of product.Meanwhile, in order to improve, grape is acid and sweet taste inadequate, adopts to add appropriate isomaltoketose sweetener and strengthen mouthfeel and promote the effect of promoting the production of body fluid in this prescription, is conducive to diabetic to take, raising product function.
In order to reach above-mentioned effect, inventor has done a large amount of experiments, and part research conditions is as follows:
One, adhesive screening
In order to solve preparations shaping problem, the adhesives such as dextrin, sodium carboxymethylcellulose, gelatin, slurry glucose, polyvinylpyrrolidone are tried out, but because mouthfeel or granulation and molding effect bad and abandon, finally determine in preparations shaping, to select Arabic gum and honey as combination adhesive, in table 1.
Table 1 adhesive the selection result table (unit: g)
The above results shows, formula 1,7 weak effects, can not be for the production of, and formula 2-6 molding effect is better, and can be used for large production, 4 effects of wherein filling a prescription are best, and mouthfeel is good.
Two, sweetener screening
Sucrose, stevioside, saccharin sodium, xylitol, maltitol etc. have been tried out, in table 2 in test.
Table 2 sweetener the selection result table (unit: g)
Remarks: "+" is more, effect is better.
Above-mentioned result of the test shows, selects isomaltoketose to do sweetener mouthfeel best, gentle fine and smooth.And having certain adhesive effect, hygroscopicity is very low, is beneficial to storage.
In a word, the present invention, by lot of experiments, is preferably applicable to the characteristic supplementary material composition of vitamine C sodium, and prescription composition science, technique is unique, and without the need to adding the industrial chemicals such as pigment, essence, product safety performance is high.By the lozenge that this prescription makes, mouthfeel is good, taking convenience, and retaining original grape juice original flavor and enhance vitamine C sodium function, is a kind of good vitamin replenisher and health products.Meanwhile, easy, the science of prescription composition of the present invention, product bioavilability is high, effective, is applicable to all kinds of crowd's long-term taking.
Detailed description of the invention
Below in conjunction with specific embodiment, the invention will be further described, but do not limit the scope of the invention and range of application:
One, the preparation method of vitamine C sodium lozenge
Embodiment 1
A preparation method for vitamine C sodium lozenge, comprises the following steps:
1. take raw material by following weight portion: fresh grape 50kg, vitamine C sodium 10kg, isomaltoketose 15kg, Arabic gum 10kg, honey 4kg, dolomol 0.05kg.
2. get fresh grape, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice centrifuge divides gets normal juice, for subsequent use;
3. get above-mentioned grape fruit residue, add isomaltoketose, mix, adopt boulton process 80 DEG C to be dried to moisture content 3%, pulverize with the impact grinding of high energy nanometer, cross 200 mesh sieves, powder not by sieve is pulverized again, after 200 mesh sieves, the superfine powder after sieving is mixed, obtains compound grape fruit powder;
4. get above-mentioned compound grape fruit powder, add Arabic gum, mix, then add the original grape juice liquid that honey and step 2 obtain, mix softwood processed, granulate, particle 80 DEG C of vacuum drying, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
Embodiment 2
A preparation method for vitamine C sodium lozenge, comprises the following steps:
1. take raw material by following weight portion: fresh grape 120kg, vitamine C sodium 25kg, isomaltoketose 30kg, Arabic gum 20kg, honey 12kg, dolomol 0.15kg.
2. get fresh grape, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, for subsequent use;
3. get above-mentioned grape fruit residue, add isomaltoketose, mix, adopt boulton process 60 DEG C to be dried to moisture content 5%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound grape fruit powder;
4. get above-mentioned compound grape fruit powder, add Arabic gum, mix, add the original grape juice liquid that honey and step 2 obtain again, mix softwood processed, granulate, particle, 60 DEG C of vacuum drying, is pulverized after making particle drying for the first time, then adopts remaining original grape juice liquid to granulate, until original grape juice liquid is finished, whole grain, particle adds vitamine C sodium, dolomol, mixes, compressing tablet, to obtain final product.
Embodiment 3
A preparation method for vitamine C sodium lozenge, comprises the following steps:
1. take raw material by following weight portion: fresh grape 80kg, vitamine C sodium 15kg, isomaltoketose 20kg, Arabic gum 15kg, honey 7kg, dolomol 0.1kg.
2. get fresh grape, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, for subsequent use;
3. get above-mentioned grape fruit residue, add isomaltoketose, mix, adopt boulton process 40 DEG C to be dried to moisture content 10%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound grape fruit powder;
4. get above-mentioned compound grape fruit powder, add Arabic gum, mix, then add the original grape juice liquid that honey and step 2 obtain, mix softwood processed, granulate, particle 40 DEG C of vacuum drying, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
Embodiment 4
A preparation method for vitamine C sodium lozenge, comprises the following steps:
1. take raw material by following weight portion: fresh grape 100kg, vitamine C sodium 30kg, isomaltoketose 35kg, Arabic gum 25kg, honey 15kg, dolomol 0.20kg.
2. get fresh grape, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, and 60 DEG C of reduced pressure concentrations become appropriate concentrate, for subsequent use;
3. get above-mentioned grape fruit residue, add isomaltoketose, mix, adopt boulton process 60 DEG C to be dried to moisture content 8%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound grape fruit powder;
4. get above-mentioned compound grape fruit powder, add Arabic gum, mix, then add the grape concentrate that honey and step 2 obtain, mix softwood processed, granulate, particle 60 DEG C of vacuum drying, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
Embodiment 5
A preparation method for vitamine C sodium lozenge, comprises the following steps:
1. take raw material by following weight portion: fresh grape 90kg, vitamine C sodium 20kg, isomaltoketose 15kg, Arabic gum 17.5kg, honey 9.5kg, dolomol 0.15kg.
2. get fresh grape, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice divides with 300 mesh filter screens gets normal juice, for subsequent use;
3. get above-mentioned grape fruit residue, add isomaltoketose, mix, adopt boulton process 50 DEG C to be dried to moisture content 6%, pulverize with the impact grinding of high energy nanometer, cross 300 mesh sieves, powder not by sieve is pulverized again, after 300 mesh sieves, the superfine powder after sieving is mixed, obtains compound grape fruit powder;
4. get above-mentioned compound grape fruit powder, add Arabic gum, mix, add the original grape juice liquid that honey and step 2 obtain again, mix softwood processed, granulate, particle, 50 DEG C of vacuum drying, is pulverized after making particle drying for the first time, then adopts remaining original grape juice liquid to granulate, until original grape juice liquid is finished, whole grain, particle adds vitamine C sodium, dolomol, mixes, compressing tablet, to obtain final product.
Two, subjective appreciation
By above-mentioned 5 the embodiment samples prepared, allow 50 people foretaste respectively, carry out sense organ investigation evaluation.Evaluation project has: lozenge structural state, color and luster, local flavor, mouthfeel, and recycling weighting method calculates total score, and structural state weight coefficient is 0.2, and color and luster weight coefficient is 0.2, and local flavor weight coefficient is 0.3, mouthfeel weight coefficient, and 0.3, the results are shown in Table 3.
Table 3 lozenge results of sensory evaluation table
Above-mentioned result of the test shows, 5 embodiment samples that the present invention prepares, and subjective appreciation is effective, and weight score is more than 7 points.Illustrate that the present invention can retain the distinctive active ingredient of grape, fragrance and color and luster, and pomace add isomaltoketose drying after adopt micronizer to pulverize, and add honey softwood, the products taste of preparation is fine and smooth, fresh and sweet, retaining original grape juice original flavor and enhance vitamine C sodium function, is a kind of good vitamin replenisher and health products; Adopt original grape juice liquid multi granulating, and particle drying adopts vacuum drying method, the lozenge fragrance obtained is stronger, and rate of drying is also very fast.Production technology of the present invention is unique, and formed product is good, and technique is simple, easy to operate, can be applicable to suitability for industrialized production.
Claims (6)
1. a vitamine C sodium lozenge, it is characterized in that, raw material is made up of the component of following weight portion: fresh grape 500-1200 part, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
2. vitamine C sodium lozenge according to claim 1, it is characterized in that, raw material is made up of the component of following weight portion: fresh grape 800-1000 part, vitamine C sodium 150-250 part, isomaltoketose 200-300 part, Arabic gum 150-200 part, honey 70-120 part, dolomol 1-1.5 part.
3. vitamine C sodium lozenge according to claim 1, it is characterized in that, raw material is made up of the component of following weight portion: fresh grape 900 parts, vitamine C sodium 200 parts, isomaltoketose 150 parts, Arabic gum 175 parts, honey 95 parts, dolomol 1.0 parts.
4. a preparation method for vitamine C sodium lozenge as claimed in claim 1, is characterized in that, comprise the following steps:
(1) raw material is taken by following weight portion: fresh grape 500-1200 part, vitamine C sodium 100-300 part, isomaltoketose 150-350 part, Arabic gum 100-250 part, honey 40-150 part, dolomol 0.5-2 part.
(2) get fresh grape, clean, remove the peel, remove seed, put in juice extractor and squeeze Normal juice, fruit juice centrifuge or 200-300 mesh filter screen divide gets normal juice, for subsequent use;
(3) get above-mentioned grape fruit residue, add isomaltoketose, mix, be dried to moisture content 3-10%, be ground into compound pomace fine powder, cross 200-300 mesh sieve, obtain compound grape fruit powder;
(4) get above-mentioned compound grape fruit powder, add Arabic gum, mix, then add the original grape juice liquid that honey and step (2) obtain, softwood processed, granulates, dry, whole grain, particle adds vitamine C sodium, dolomol, mixes, and compressing tablet to obtain final product.
5. the preparation method of vitamine C sodium lozenge according to claim 4, is characterized in that, the granulation step in described step (4) adopts multi granulating method: pulverize after making particle drying for the first time, then adopt original grape juice liquid multi granulating; And particle drying adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
6. the preparation method of vitamine C sodium lozenge according to claim 4, is characterized in that, described step (3) drying steps adopts vacuum drying method, and baking temperature is 40 DEG C-60 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764369.XA CN104544049A (en) | 2014-12-11 | 2014-12-11 | Vitamin C sodium lozenge and preparation process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410764369.XA CN104544049A (en) | 2014-12-11 | 2014-12-11 | Vitamin C sodium lozenge and preparation process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104544049A true CN104544049A (en) | 2015-04-29 |
Family
ID=53061971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410764369.XA Pending CN104544049A (en) | 2014-12-11 | 2014-12-11 | Vitamin C sodium lozenge and preparation process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104544049A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260725A (en) * | 2017-06-01 | 2017-10-20 | 防城港圣保堂制药有限公司 | A kind of ion VC lozenges and preparation method thereof |
| CN107495203A (en) * | 2017-08-11 | 2017-12-22 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing hawthorn and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1653920A (en) * | 2004-02-11 | 2005-08-17 | 白峰 | Tea buccal tablet and its manufacturing method |
| CN1803018A (en) * | 2006-01-20 | 2006-07-19 | 邱锦耀 | Production method of fruit vitamin C tablets |
| CN101822382A (en) * | 2010-03-30 | 2010-09-08 | 杭州英仕利生物科技有限公司 | Fruity tea polyphenol buccal tablet and preparation method thereof |
| US20120219539A1 (en) * | 2009-11-17 | 2012-08-30 | Gyu-Gil Lee | Method for Preparing Raw Material for Functional Foods from Barley or Wheat Seeds |
| CN103141786A (en) * | 2013-04-03 | 2013-06-12 | 石林绿汀甜柿产品开发有限公司 | Persimmon buccal tablet candy |
| CN103461638A (en) * | 2013-09-17 | 2013-12-25 | 南京通泽农业科技有限公司 | Ginger juice and brown sugar tablet and preparation method thereof |
| CN104107316A (en) * | 2014-07-30 | 2014-10-22 | 陈顺美 | Fruity buccal tablet |
-
2014
- 2014-12-11 CN CN201410764369.XA patent/CN104544049A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1653920A (en) * | 2004-02-11 | 2005-08-17 | 白峰 | Tea buccal tablet and its manufacturing method |
| CN1803018A (en) * | 2006-01-20 | 2006-07-19 | 邱锦耀 | Production method of fruit vitamin C tablets |
| US20120219539A1 (en) * | 2009-11-17 | 2012-08-30 | Gyu-Gil Lee | Method for Preparing Raw Material for Functional Foods from Barley or Wheat Seeds |
| CN101822382A (en) * | 2010-03-30 | 2010-09-08 | 杭州英仕利生物科技有限公司 | Fruity tea polyphenol buccal tablet and preparation method thereof |
| CN103141786A (en) * | 2013-04-03 | 2013-06-12 | 石林绿汀甜柿产品开发有限公司 | Persimmon buccal tablet candy |
| CN103461638A (en) * | 2013-09-17 | 2013-12-25 | 南京通泽农业科技有限公司 | Ginger juice and brown sugar tablet and preparation method thereof |
| CN104107316A (en) * | 2014-07-30 | 2014-10-22 | 陈顺美 | Fruity buccal tablet |
Non-Patent Citations (1)
| Title |
|---|
| 小业JIEY: "石药牌果维康维生素C含片", 《百度百科》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107260725A (en) * | 2017-06-01 | 2017-10-20 | 防城港圣保堂制药有限公司 | A kind of ion VC lozenges and preparation method thereof |
| CN107495203A (en) * | 2017-08-11 | 2017-12-22 | 防城港圣保堂制药有限公司 | A kind of ion Vc composition containing hawthorn and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102224891B (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN104605224A (en) | Original pineapple flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN104546955A (en) | Raw kiwifruit flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN105494844A (en) | Production method of Chinese wolfberry fruit tablet candy | |
| CN104738624A (en) | Nutritional health-care food for neurasthenia, amnesia and insomnia | |
| CN104286273A (en) | Application of dendrobium candidum and tea leaf product thereof | |
| CN107303280A (en) | Okra chews tablet composition and preparation method thereof | |
| CN103876142A (en) | Superfine powder chewable tablets with functions of beautifying and slimming, and preparation method thereof | |
| CN104544047B (en) | A kind of former orange taste sodium ascorbate buccal tablet and preparation technology thereof | |
| CN102132821A (en) | Formula nutritious rice and preparation method | |
| CN101095490A (en) | Method for preparation of flavored chickpea bolus | |
| CN104544048A (en) | Buccal tablet with composite vitamin C sodium and preparation method thereof | |
| KR100725182B1 (en) | Laver fortified functionality using natural plant material and a manufacturing method thereof | |
| CN105010635A (en) | Health-care dandelion bag tea and preparation method thereof | |
| CN104544049A (en) | Vitamin C sodium lozenge and preparation process thereof | |
| CN107751778A (en) | A kind of high microsteping content health caring noodles with effects for removing toxic heat and preparation method thereof | |
| CN103271353B (en) | Liver protecting and health care composition and preparation method thereof | |
| CN104605223A (en) | Original strawberry flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN105994740A (en) | Green tea with dendrobium officinale and method for preparing green tea | |
| CN105285284A (en) | Grifola frondosa domestic fungus pressed candy and making method thereof | |
| CN104839699A (en) | Heart disease non-total nutrient formula food | |
| CN104544114A (en) | Multivitamin buccal tablets | |
| CN104605374A (en) | Original juicy peach flavor vitamin C sodium buccal tablet and preparation process thereof | |
| CN103125931A (en) | Novel energy replenisher | |
| CN104605280A (en) | Snow pear-containing buccal tablet and preparation technology thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |